ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Prior notification of a concentration

(Case M.10519 – BLACKSTONE / INTERPLEX)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 492/04)

1. On 1 December 2021, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Blackstone Inc. (‘Blackstone’, United States); — Interplex Holdings Pte. Ltd (‘Interplex’, Singapore). Blackstone acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Interplex. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Blackstone: global asset management across a wide range of assets classes including private equity, real estate, public debt and equity, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds; — for Interplex: design and manufacture of customised interconnect, high-precision and mechanical solutions focused on decarbonisation of transportation, future mobility, increased longevity and digitalisation, serving clients globally.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10519 – BLACKSTONE / INTERPLEX Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.10411 – ABM / YKA / HEBEI MAURI)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 514 I/04)

1. On 14 December 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Associated British Foods plc (‘ABF’, United Kingdom), — Wilmar International Limited (‘Wilmar’, Singapore), — AB Mauri Yihai Kerry Investment Company Limited (‘AB Mauri’, China), a full-function joint venture between ABF and Wilmar, — Hebei Mauri Food Co., Ltd. (‘Hebei Mauri’ or the ‘Target’ China), controlled by ABF. Through AB Mauri, ABF and Wilmar acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of Hebei Mauri. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for ABF: active in five main business domains worlwide, namely (i) production of baking ingredients, including yeast; (ii) production of sugar; (iii) manufacture of grocery products; (iv) supply of agricultural products to farmers; and (v) high street retailing, — for Wilmar: active in oil palm cultivation, oilseed crushing, edible oil refining, sugar milling and refining, manufacturing of consumer products, specialty fats, oleochemicals, biodiesel and fertilisers as well as flour and rice milling worldwide, — for Hebei Mauri: active in the manufacture and supply of bakers’ yeast to China and other countries, including in Asia; and — for AB Mauri: active in the manufacture, sale and distribution of yeast, bakery ingredients and bakery fats in Asia, as well as the provision of relevant bakery and technical services related to these products in Asia.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10411 – ABM / YKA / HEBEI MAURI Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10528 – ADVENT / EURAZEO / PROTEL)

(Text with EEA relevance)

(2021/C 509/01)

On 9 December 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10528. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.10448 – MABANAFT / H&R / P2X)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 8/02)

1. On 22 December 2021, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Mabanaft GmbH & Co. KG (‘Mabanaft’, Germany), belonging to the Marquard & Bahls Group, whose ultimate parent is Marquard & Bahls AG (Germany), — H&R GmbH & Co. KGaA (‘H&R’, Germany), as the ultimate parent company of the H&R Group, — P2X-Europe GmbH & Co. KG (‘P2X’, Germany). Mabanaft and H&R acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of P2X. The concentration is accomplished by way of contract or any other means.

2. The business activities of the undertakings concerned are: — for Mabanaft: Mabanaft is part of Marquard & Bahls Group which is active in the supply, trading and logistics of energy, petroleum products and chemicals, — for H&R: H&R is part of H&R Group. The main activities of H&R Group comprise the development, production, filling and marketing of specialty chemical-pharmaceutical products based on crude oil such as process oils, plasticizers, white oils, base oils and paraffins, — for P2X: P2X’ activities concern the so-called PtX technology and business. PtX stands for energy conversion processes that are used to convert preferably renewable sources of power to synthetic end products such as gases, liquids, chemical products or heat. PtX plants can produce synthetic hydrocarbons from water and carbon dioxide using electrical energy. Possible PtX products are, for example, synthetic and climate-neutral e-fuels such as petrol, diesel, jet fuel or waxes.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10448 – MABANAFT / H&R / P2X Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10552 – BROOKFIELD / ACEK / BENJUMEA FAMILY / POWEN)

(Text with EEA relevance)

(2022/C 27/01)

On 13 January 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10552. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10428 – CDPQ / OTPPB / CMLIC)

(Text with EEA relevance)

(2022/C 21/02)

On 22 October 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10428. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.10548 – TELEKOM DEUTSCHLAND / IFM INVESTORS / JV)

(Text with EEA relevance)

(2022/C 49/05)

On 25 January 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10548. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10526 – CHEVRON / NESTE BASE OIL)

(Text with EEA relevance)

(2022/C 38 I/03)

1. On 18 January 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Chevron Global Energy Inc. (‘Chevron’, USA), controlled by Chevron — Corporation (USA), — Neste Base Oil Finland Oy (‘Neste Base Oil’, Finland), controlled by Neste Oyj (Finland). Chevron will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Neste Base Oil. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned: — Chevron: active in the production of crude oil and natural gas, the manufacturing of transportation fuels, lubricants, petrochemicals and additives, — Neste Base Oil: Neste’s base oil business consists of a carve out from Neste Oyj’s Oil Products business segment and consists mainly of the NEXBASE™ brand, associated qualifications and approvals, sales and logistics contracts as well as an offtake agreement for the production and delivery of Group III and Group II base oils. It does not include any production facilities.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10526 – CHEVRON / NESTE BASE OIL Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Prior notification of a concentration

(Case M.10570 - ADVENT / PERMIRA / MCAFEE)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 66/06)

1. On 31 January 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Permira Holdings Limited (‘Permira’, UK), — Advent International Corporation (‘Advent’, US), — McAfee Corp. (‘McAfee’, US). Permira and Advent acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of McAfee. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Permira: provision of investment management services to a number of investment funds. Permira controls a number of portfolio companies which are active in a variety of sectors across a range of jurisdictions; — for Advent: acquisition of equity stakes and management of investment funds in various sectors, including healthcare, industrial, technology, retail, consumer and leisure, and business and financial services; — for McAfee: provision of advanced security solutions to consumers. McAfee is active in the design and development of security products and services focused in particular on ensuring that internet connected devices are protected from malicious content.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10570 - ADVENT / PERMIRA / MCAFEE Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10567 – ACE / MOSADEX / PHARMALOT COMPOUNDING)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 56/03)

1. On 25 January 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Ace Holding B.V. (‘Ace’, Netherlands), controlled by GMC VI B.V. (Netherlands), Quadrum Investment Fund III B.V. (Netherlands) and Coöperatieve Gilde Healthcare Services U.A. (Netherlands), — Mosadex Holding B.V. (‘Mosadex’, Netherlands), — Pharmalot Compounding B.V. (‘Pharmalot’, Netherlands), controlled by Mosadex and Basic Pharma Holding B.V. (Netherlands). Ace and Mosadex will acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of the whole of Pharmalot. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Ace is active in the development, production, registration and sale of medicines for small patient population or niche indications, — Mosadex is active in the sourcing and wholesale of medicines, medical devices and health products, — Pharmalot is active in the production and supply of pharmacy preparations.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10567 – ACE / MOSADEX / PHARMALOT COMPOUNDING Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.10546 – ICG / CEIT)

(Text with EEA relevance)

(2022/C 72/01)

On 25 January 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10546. EUR-Lex is the online point of access to European Union law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.10601 – WARBURG PINCUS / OXFORD PROPERTIES / HALE)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 69/13)

1. On 26 January 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Warburg Pincus LLC (‘“Warburg Pincus”’, USA), — Oxford Properties Asia Holdings I Pte. Ltd. (‘“Oxford Properties”’, Canada), — Hale Capital Group Pty Ltd (‘“Hale”’, Australia). Warburg Pincus and Oxford Properties acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of Hale. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Warburg Pincus: a global private equity firm active in a variety of sectors, including consumer, energy, financial services, healthcare, industrial and business services, real estate and technology. — for Oxford Properties: the ownership, development and managing of real estate assets. Oxford Properties belongs to the real estate arm of OMERS Administration Corporation (‘OMERS’), the administrator of the Ontario Municipal Employees Retirement System Primary Pension Plan and trustee of the pension funds. — for Hale: the development and managing of a portfolio of industrial real estate investments in the Asia-Pacific region.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.10601 – WARBURG PINCUS / OXFORD PROPERTIES / HALE Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.